TENB2, a proteoglycan identified in prostate cancer that is associated with disease progression and androgen independence
Open Access
- 10 September 2001
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 94 (2) , 178-184
- https://doi.org/10.1002/ijc.1450
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Differentially Expressed Genes in Two LNCaP Prostate Cancer Cell Lines Reflecting Changes during Prostate Cancer ProgressionLaboratory Investigation, 2000
- Potential Mechanisms for the Regulation of Growth Factor Binding by HeparinJournal of Theoretical Biology, 2000
- IDENTIFICATION OF AN ACTIVIN-FOLLISTATIN GROWTH MODULATORY SYSTEM IN THE HUMAN PROSTATE: SECRETION AND BIOLOGICAL ACTIVITY IN PRIMARY CULTURES OF PROSTATIC EPITHELIAL CELLSJournal of Urology, 1999
- Follistatin: A Multifunctional Regulatory ProteinFrontiers in Neuroendocrinology, 1998
- Expression and Localization of Activin Subunits and Follistatins in Tissues from Men with High Grade Prostate CancerJournal of Clinical Endocrinology & Metabolism, 1997
- Analysis of glycosaminoglycans in human prostate by high‐performance liquid chromatographyPublished by Wiley ,1997
- Influence of testosterone on chondroitin sulphate proteoglycan in the rat prostateBiochemistry and Cell Biology, 1996
- Isolation of cDNAs that are differentially expressed between androgen‐dependent and androgen‐independent prostate carcinoma cells using differential display PCRThe Prostate, 1995
- Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain ReactionScience, 1992
- Growth factors and receptors in cancerCurrent Opinion in Biotechnology, 1991